{"id":476772,"date":"2020-03-30T15:00:01","date_gmt":"2020-03-30T15:00:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=476772"},"modified":"2020-03-30T15:00:01","modified_gmt":"2020-03-30T15:00:01","slug":"hidradenitis-suppurativa-hs-epidemiology-forecast-to-2030","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/hidradenitis-suppurativa-hs-epidemiology-forecast-to-2030_476772.html","title":{"rendered":"Hidradenitis Suppurativa (HS) Epidemiology Forecast to 2030"},"content":{"rendered":"
\"Hidradenitis<\/a><\/p>\n
\n
DelveInsight Business Research LLP<\/div>\n<\/div>\n<\/div>\n
DelveInsight\u2019s \u2018Hidradenitis Suppurativa (HS) – Epidemiology Forecast to 2030\u2019 report delivers an in-depth understanding of the disease, historical and forecasted Hidradenitis Suppurativa epidemiology in the 7MM, i.e., the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.<\/p>\n<\/div>\n

DelveInsight<\/strong> launched its new report on Hidradenitis Suppurativa (HS) – Epidemiology Forecast to 2030<\/a>.<\/strong><\/p>\n

DelveInsight’s ‘Hidradenitis Suppurativa (HS) – Epidemiology Forecast to 2030<\/strong>’ report delivers an in-depth understanding of the disease, historical and forecasted Hidradenitis Suppurativa epidemiology in the 7MM, i.e., the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.<\/p>\n

“The total prevalent population of HidradenitisSuppurativain 7MM was found to be 6,851,308 in 2017.”<\/strong><\/p>\n

Scope of the report:<\/strong>
1. The HS report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
2. The HS Report and Model provide an overview of the risk factors and global trends of HS in the seven major markets (7MM: US, Germany, France, Italy, Spain, and the United Kingdom, and Japan)
3. The report provides insight into the historical and forecasted patient pool of HS in seven major markets covering the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom) and Japan
4. The report helps to recognize the growth opportunities in the 7MM with respect to the patient population
5. The report assesses the disease risk and burden and highlights the unmet needs of HS
6. The report provides the segmentation of the HS epidemiology by Age-specific diagnosed prevalent Cases of HS in 7MM
7. The report provides the segmentation of the HS epidemiology by Gender-specific diagnosed prevalent Cases of HS in 7MM
8. The report provides the segmentation of the HS epidemiology by Stage-Specific diagnosed prevalent Cases of HS in 7MM<\/p>\n

\"\"<\/strong><\/p>\n

Reports highlights:<\/strong>
1. 11-Year Forecast of Hidradenitis Suppurativa epidemiology
2. 7MM Coverage
3. Total Diagnosed prevalent Cases of Hidradenitis Suppurativa
4. Diagnosed Prevalent Cases according to segmentation: Gender-specific, Age-specific, Stage-specific Incidence
5. Treated cases of Hidradenitis Suppurativa<\/p>\n

Table of contents:
<\/strong>1. Key Insights
2. Executive Summary: Hidradenitis Suppurativa (HS)
3. SWOT Analysis: Hidradenitis Suppurativa (HS)
4. Hidradenitis Suppurativa (HS) Patient Share (%) Overview at a Glance
5. Hidradenitis Suppurativa Market Overview at a Glance
6. Disease Overview: Hidradenitis Suppurativa (HS)
7. Epidemiology and Patient Population
8. Country-wise Epidemiology of HS in the 7MM
9. Appendix
10. Disclaimer
11. DelveInsight Capabilities
12. About DelveInsight<\/p>\n

Related reports: <\/strong><\/p>\n

Hidradenitis Suppurativa (HS)-Market Insights, Epidemiology and Market Forecast-2030<\/a><\/p>\n

Hidradenitis – Market Insights, Epidemiology, and Market Forecast-2030<\/a><\/p>\n

Hidradenitis – Epidemiology Forecast to 2030<\/a><\/p>\n

Hidradenitis Pipeline Insight, 2020<\/a> <\/p>\n

Media Contact<\/span>
Company Name:<\/strong> DelveInsight Business Research LLP<\/a>
Contact Person:<\/strong> Kritika Rehani
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> 9193216187
Address:<\/strong>304 S. Jones Blvd #2432
City:<\/strong> Las Vegas
State:<\/strong> Nevada
Country:<\/strong> United States
Website:<\/strong> https:\/\/www.delveinsight.com\/<\/a><\/p>\n

<\/object>\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

DelveInsight Business Research LLP DelveInsight\u2019s \u2018Hidradenitis Suppurativa (HS) – Epidemiology Forecast to 2030\u2019 report delivers an in-depth understanding of the disease, historical and forecasted Hidradenitis Suppurativa epidemiology in the 7MM, i.e., the United States, EU5 (Germany, France, Italy, Spain, and … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,435,405,406,404],"tags":[],"class_list":["post-476772","post","type-post","status-publish","format-standard","hentry","category-Business","category-Europe","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/476772","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=476772"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/476772\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=476772"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=476772"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=476772"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}